secwatch.observer — SEC 8-K summary
======================================

Issuer:     Talis Biomedical Corp (—)
CIK:        0001584751
Form:       8-K
Filed at:   2024-05-03T23:59:59+00:00
Accession:  0000950170-24-052949
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Talis Biomedical extends waiver of registration rights with Baker Brothers through May 27, 2024
--------------------------------------------------------------------------------

- Company and Baker Brothers entities agree to extend waiver of registration rights originally set for 30 days.
- Waiver now runs through May 27, 2024, covering all registrable securities beneficially owned by the stockholders.
- Extension follows termination of S-3 registration statement in March 2024 due to company no longer being eligible.
- Waiver applies to Sections 2.1(a) and 2.1(b) of the Registration Rights Agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1584751/000095017024052949/0000950170-24-052949-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1584751/000095017024052949/tlis-20240429.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-052949

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer